Showing results (2151-2160 of 10,589) with videos related to
Sort By:
Pageof 1,059
Thrombosis Research|May 11, 2016
PO-11 - Thrombin and cancer stem-like cells: in vitro support for breast cancer anticoagulationJ Castle, G Farnie, C C KirwanThrombosis Research|May 11, 2016
PO-12 - The key role of talin-1 in cancer cell extravasation dissected through human vascularized 3D microfluidic modelM Gilardi, S Bersini, A Boussomier Calleja, et al.Thrombosis Research|May 11, 2016
PO-18 - Fibronectin EDA/EDB is expressed in adherent SCLC NCI-H69 cells and in pleural effusions of lung cancer patients: possible implication for drug resistanceU Salge-Bartels, M Heiden, R Seitz, et al.Thrombosis Research|May 11, 2016
PO-17 - Identification of IgG bound to plasminogen in oncologic diseasesV N Iakovlev, E I Goufman, N B Tikhonova, et al.Thrombosis Research|May 11, 2016
PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1D Pinessi, C Foglieni, A Bugatti, et al.Thrombosis Research|May 11, 2016
PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancersC Fourgeaud, S Derieux, S Mirshahi, et al.Thrombosis Research|May 11, 2016
PO-28 - Protein C levels are associated with mortality in patients with advanced cancerI T Wilts, B A Hutten, J C Meijers, et al.Thrombosis Research|May 11, 2016
PO-30 - Changes in soluble CD106 and CD54 serum levels during chemotherapy treatment for multiple myelomaJ Hall, M A Adesanya, L A Madden, et al.Thrombosis Research|May 11, 2016
PO-36 - Thrombin Inhibition Preoperatively (TIP) in early breast cancer, the first clinical trial of NOACs as an anti-cancer agent: trial methodologyC C Kirwan, N J Bundred, J Castle, et al.Thrombosis Research|May 11, 2016
PO-37 - Optimization of the anticoagulant therapy in cancer patientsA Vorobev, A MakatsariaPageof 1,059